Phase
Condition
Cancer
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patient with histologically-confirmed cancer
- Patient harboring a rare actionable fusion (see Appendix 1),
- Availability of clinical and demographic data, information on treatment and clinicaloutcome.
- Adult, ≥18 years old,
- Patient should understand, sign and date the written voluntary informed consent form.
Exclusion
Exclusion Criteria:
Study Design
Study Description
Connect with a study center
University Hospital Graz
Graz,
AustriaSite Not Available
Medical University of Vienna
Vienna,
AustriaSite Not Available
Masaryk Memorial Cancer Institute (Masarykuv Onkologicky Ustav)
Brno,
CzechiaSite Not Available
Aarhus University Hospital
Aarhus,
DenmarkSite Not Available
Chu Jean Minjoz
Besançon,
FranceSite Not Available
Institut Bergonie
Bordeaux,
FranceActive - Recruiting
Centre Georges Francois Leclerc
Dijon,
FranceSite Not Available
Centre Oscar Lambret
Lille, 59020
FranceSite Not Available
Chu Dupuytren
Limoges,
FranceSite Not Available
Centre Léon Bérard
Lyon, 69008
FranceActive - Recruiting
Assistance Publique Hopitaux de Marseille (AP-HM)
Marseille,
FranceSite Not Available
Centre Antoine Lacassagne
Nice,
FranceSite Not Available
Aphp - Hopital Cohin
Paris, 75014
FranceSite Not Available
Aphp - Hopital Tenon
Paris, 75020
FranceSite Not Available
Aphp - Hopital de La Pitie Salpetriere
Paris, 75013
FranceSite Not Available
Institut Curie
Paris, 75005
FranceSite Not Available
Centre Henri Becquerel
Rouen,
FranceSite Not Available
Institut Claudius Regaud
Toulouse,
FranceSite Not Available
"Hämato-Onkologischer Studienkreis MVZ am Klinikum Aschaffenburg / Onkologie"
Aschaffenburg,
GermanySite Not Available
Charité - Universitätsmedizin Berlin
Berlin,
GermanySite Not Available
"Klinik für Innere Medizin III, Hämatologie, Onkologie Klinikum Chemnitz"
Chemnitz,
GermanySite Not Available
"Medizinische Klinik 1- Gastroenterologie, Hepatologie, Pneumologie Universitätsklinikum Frankfurt"
Frankfurt am main,
GermanySite Not Available
"Hämatologisch-onkologische Ambulanz Universitätsklinikum Halle"
Halle,
GermanySite Not Available
"Klinik für Gastroenterologie, Hepatologie und Infekt Universitätsklinikum Magdeburg"
Magdeburg,
GermanySite Not Available
Mannheim University Medical Center (UniversitatsMedizin Mannheim)
Mannheim,
GermanySite Not Available
"Medizinische Klinik und Poliklinik III LMU - Klinikum der Universität München"
München,
GermanySite Not Available
"Klinik für Innere Medizin III, Hämatologie, Onkologie Südharzklinikum"
Nordhausen,
GermanySite Not Available
Universitätsklinikum Tübingen Medizinische Universitätsklinik;
Tübingen,
GermanySite Not Available
University Hospital Würzburg (UniversitätsKlinikum Würzburg)
Würzburg,
GermanySite Not Available
Azienda Ospedaliera - Universitaria - Policlinico S Orsola-Malpighi Univertsita di Bologna
Bologna,
ItalySite Not Available
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Meldola,
ItalySite Not Available
Fondazione IRCCS Istituto Neurologico Carlo Besta
Milano,
ItalySite Not Available
IRCCS Ospedale San Raffale
Milano,
ItalySite Not Available
CRTR-AOU Federico II
Napoli,
ItalySite Not Available
Azienda Ospedaliero - Universitaria Cita della Salute e della Scienza di Torino
Torino,
ItalySite Not Available
Leiden University Medical Center
Leiden,
NetherlandsSite Not Available
Maria Sklodowska Curie National Research Institute of Oncology
Warsaw,
PolandSite Not Available
Institute of Oncology of Ljubljana
Ljubljana,
SloveniaSite Not Available
Complejo Hospitalario regional Virgen del Rocio
Sevilla,
SpainSite Not Available
The Royal Marsden NHS Foundation Trust
London,
United KingdomSite Not Available
University College London NHS Foundation Trust
London,
United KingdomSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.